What should you know about IgA MGUS?

Immunoglobulin A, or IgA, is an antibody made by plasma cells. In MGUS, one group of plasma cells makes a matching antibody, called a monoclonal protein. The finding is not the same as multiple myeloma, and many people have no symptoms from it.

Your clinician interprets the result alongside the amount of monoclonal protein, blood counts, kidney measurements, calcium, and sometimes urine testing or imaging. These checks help distinguish a stable finding from signs that the bone marrow or organs may be affected.

Keep the follow-up appointments arranged by your haematology team. Monitoring may include repeat blood tests, urine tests, and a review of new symptoms. Bring previous laboratory reports so changes can be assessed consistently.

There is usually no treatment aimed at MGUS itself when it is stable. Maintain your usual activities unless another condition limits them, and tell your clinician about medicines or supplements before testing.

Contact your medical team promptly for new or worsening bone pain, unusual tiredness, repeated infections, unexplained weight change, swelling, reduced urine, or persistent numbness. Seek urgent help for sudden weakness, severe breathing difficulty, confusion, or loss of bladder control.

Ask which IgA result was found, whether the monoclonal protein is stable, which tests are planned next, and what interval is appropriate for review. You can also ask what symptoms should trigger an earlier appointment and whether a haematology referral is needed.